{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:10:09Z","timestamp":1791987009890,"version":"4.4.0"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02432","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:25:22Z","timestamp":1540340722000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":219,"title":["IL-33\/ST2 Axis in Organ Fibrosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Ourania S.","family":"Kotsiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios G.","family":"Zarogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/00004647-199911000-00013","article-title":"Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage","volume":"19","author":"Onda","year":"1999","journal-title":"J Cerebr Blood Flow Met."},{"key":"B2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0002-9440(10)63631-0","article-title":"Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules","volume":"163","author":"Baekkevold","year":"2003","journal-title":"Am J Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity."},{"key":"B4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.immuni.2005.10.004","article-title":"An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor","volume":"23","author":"Dinarello","year":"2005","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2019?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS ONE"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1422.e11","DOI":"10.1016\/j.jaci.2014.05.011","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"Li","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/imr.12552","article-title":"L-33: biological properties, functions, and roles in airway disease","volume":"278","author":"Drake","year":"2017","journal-title":"Immunol Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e78099","DOI":"10.1371\/journal.pone.0078099","article-title":"IL-33, but not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis","volume":"8","author":"Nakanishi","year":"2013","journal-title":"PLoS ONE"},{"key":"B9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1684\/ecn.2012.0320","article-title":"Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members","volume":"23","author":"Lefran\u00e7ais","year":"2012","journal-title":"Eur Cytokine Netw."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1073\/pnas.1115884109","article-title":"IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G","volume":"109","author":"Lefrancais","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"15502","DOI":"10.1073\/pnas.1410700111","article-title":"Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells","volume":"111","author":"Lefran\u00e7ais","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbrc.2009.07.018","article-title":"Mature interleukin-33 is produced by calpain-mediated cleavage in vivo","volume":"387","author":"Hayakawa","year":"2009","journal-title":"Biochem Biophys Res Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fimmu.2015.00232","article-title":"Alarmin' immunologists: IL-33 as a putative target for modulating T cell-dependent responses","volume":"6","author":"Gajardo","year":"2015","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The biology of ST2: the international ST2 consensus panel","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"8B","DOI":"10.1016\/j.amjcard.2015.01.035","article-title":"Soluble ST2\u2013analytical considerations","volume":"115","author":"Mueller","year":"2015","journal-title":"Am J Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12890-017-0380-z","article-title":"Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Pulm Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1189\/jlb.3RU0115-012R","article-title":"The potential role of IL-33\/ST2 signaling in fibrotic diseases","volume":"98","author":"Gao","year":"2015","journal-title":"J Leukoc Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/ard.2009.119321","article-title":"The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis","volume":"69","author":"Manetti","year":"2010","journal-title":"Ann Rheum Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.intimp.2015.11.015","article-title":"Lentivirus expressing soluble ST2 alleviates bleomycin-induced pulmonary fibrosis in mice","volume":"30","author":"Gao","year":"2016","journal-title":"Int Immunopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3892\/mmr.2016.5446","article-title":"IL33\/ST2 pathway in a bleomycin induced pulmonary fibrosis model","volume":"14","author":"Xu","year":"2016","journal-title":"Mol Med Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.4049\/jimmunol.0903306","article-title":"IL-33 induces IL-13-dependent cutaneous fibrosis","volume":"184","author":"Rankin","year":"2010","journal-title":"J Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1165\/rcmb.2013-0093OC","article-title":"Interleukin-33 potentiates bleomycin-induced lung injury. Interleukin-33 potentiates bleomycin-induced lung injury","volume":"49","author":"Luzina","year":"2013","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5314213","DOI":"10.1155\/2017\/5314213.","article-title":"IL-33-ST2 axis in liver disease: progression and challenge","volume":"2017","author":"Sun","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/cmi.2016.62","article-title":"Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells","volume":"14","author":"Weiskirchen","year":"2017","journal-title":"Cell Mol Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/CEG.S43737.","article-title":"Interleukins in chronic liver disease: lessons learned from experimental mouse models","volume":"7","author":"Hammerich","year":"2014","journal-title":"Clin Exp Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/j.1582-4934.2009.00801.x","article-title":"Interleukin-33 overexpression is associated with liver fibrosis in mice and humans","volume":"14","author":"Marvie","year":"2010","journal-title":"J Cell Mol Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/jir.2011.0109","article-title":"Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B","volume":"32","author":"Wang","year":"2012","journal-title":"J Interferon Cytokine Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1620\/tjem.234.255","article-title":"Interleukin-33 promotes disease progression in patients with primary biliary cirrhosis","volume":"234","author":"Sun","year":"2014","journal-title":"Tohoku J Exp Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1172\/JCI73742","article-title":"Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation","volume":"124","author":"Li","year":"2014","journal-title":"J Clin Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/cmi.2016.63","article-title":"Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells","volume":"15","author":"Tan","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"33649","DOI":"10.18632\/oncotarget.9259","article-title":"IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"B34","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/MOG.0000000000000378","article-title":"Pancreatic stellate cells: what's new?","volume":"33","author":"Pang","year":"2017","journal-title":"Curr Opin Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e56866","DOI":"10.1371\/journal.pone.0056866","article-title":"The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice","volume":"8","author":"Kempuraj","year":"2013","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"G821","DOI":"10.1152\/ajpgi.00178.2010","article-title":"Nuclear expression of interleukin-33 in pancreatic stellate cells","volume":"299","author":"Masamune","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.0007-1323.2001.01991.x","article-title":"Role of mast cells in the development of pancreatitis-induced multiple organ dysfunction","volume":"89","author":"Dib","year":"2002","journal-title":"Br J Surg."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.4049\/jimmunol.1700060","article-title":"Chronic fibro-inflammatory responses in autoimmune pancreatitis depend on IFN-\u03b1 and IL-33 produced by plasmacytoid dendritic cells","volume":"198","author":"Watanabe","year":"2017","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1158\/2326-6066.CIR-17-0218","article-title":"Interleukin 33 signaling restrains sporadic colon cancer in an interferon-\u03b3-dependent manner","volume":"6","author":"Eissmann","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1097\/MIB.0000000000000512","article-title":"Eosinophils and IL-33 perpetuate chronic inflammation and fibrosis in a pediatric population with Stricturing Crohn's Ileitis","volume":"21","author":"Masterson","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fimmu.2013.00181","article-title":"Opposing functions of classic and novel IL-1 family members in gut health and disease","volume":"4","author":"Lopetuso","year":"2013","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin\u2013EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/1756283X11410770","article-title":"Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation","volume":"4","author":"Pastorelli","year":"2011","journal-title":"Therap Adv Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/ibd.21175","article-title":"Characterization of the novel ST2\/IL-33 system in patients with inflammatory bowel disease","volume":"16","author":"Beltran","year":"2010","journal-title":"Inflamm Bowel Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","article-title":"Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis","volume":"45","author":"Kobori","year":"2010","journal-title":"J Gastroenterol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.2353\/ajpath.2010.100378","article-title":"Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts","volume":"177","author":"Sponheim","year":"2010","journal-title":"Am J Pathol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.imlet.2009.11.001","article-title":"IL-33 is upregulated in colonocytes of ulcerative colitis","volume":"128","author":"Seidelin","year":"2010","journal-title":"Immunol. Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu Rev Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1681\/ASN.2010091011","article-title":"IL-33 exacerbates acute kidney injury","volume":"22","author":"Akcay","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bbrc.2016.04.010","article-title":"Upregulation of Interleukin-33 in obstructive renal injury","volume":"473","author":"Chen","year":"2016","journal-title":"Biochem Biophys Res Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat Rev Nephrol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejphar.2017.06.031","article-title":"Interleukin-33 signaling contributes to renal fibrosis following ischemia reperfusion","volume":"812","author":"Liang","year":"2017","journal-title":"Eur J Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1681\/ASN.2017060650.","article-title":"Endogenous IL-33 contributes to kidney ischemia-reperfusion injury as an alarmin","volume":"29","author":"Ferhat","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1681\/ASN.2017070774","article-title":"Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury","volume":"29","author":"Cao","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3109\/0886022X.2016.1165034","article-title":"The possible role of interleukin-33 as a new player in the pathogenesis of contrast-induced nephropathy in diabetic rats","volume":"38","author":"Demirtas","year":"2016","journal-title":"Ren Fail."},{"key":"B56","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3390\/ijms18040783","article-title":"Emerging roles of IL-33\/ST2 axis in renal diseases","volume":"18","author":"Chen","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","journal-title":"J Clin Invest."},{"key":"B58","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240","article-title":"Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling","volume":"2","author":"Seki","year":"2009","journal-title":"Circ Heart Fail."},{"key":"B59","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/eci.12282","article-title":"Modulation of IL-33\/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers","volume":"44","author":"S\u00e1nchez-M\u00e1s","year":"2014","journal-title":"Eur J Clin Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2017.04.022","article-title":"Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress","volume":"138","author":"Veeraveedu","year":"2017","journal-title":"Biochem Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1479-5876-10-120","article-title":"Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress","volume":"10","author":"Zhang","year":"2012","journal-title":"J Transl Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/CIRCHEARTFAILURE.113.000457","article-title":"Soluble concentrations of the interleukin receptor family member ST2 and beta-blocker therapy in chronic heart failure","volume":"6","author":"Gaggin","year":"2013","journal-title":"Circ Heart Fail."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"6941","DOI":"10.1074\/jbc.M111.298703","article-title":"Interleukin 33 as a mechanically responsive cytokine secreted by living cells","volume":"287","author":"Kakkar","year":"2012","journal-title":"J Biol Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.imlet.2017.11.012","article-title":"The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?","volume":"195","author":"Artlett","year":"2018","journal-title":"Immunol Lett."},{"key":"B66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbrc.2015.05.081","article-title":"Single high-dose irradiation aggravates eosinophil-mediated fibrosis through IL-33 secreted from impaired vessels in the skin compared to fractionated irradiation","volume":"464","author":"Lee","year":"2015","journal-title":"Biochem Biophys Res Commun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/biof.1117","article-title":"Role of interleukin-13 in fibrosis, particularly systemic sclerosis","volume":"39","author":"O'Reilly","year":"2013","journal-title":"Biofactors"},{"key":"B68","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","article-title":"Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"30","author":"Yanaba","year":"2011","journal-title":"Clin Rheumatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"924363","DOI":"10.1155\/2013\/924363","article-title":"The role of IL-33 in rheumatic diseases","volume":"2013","author":"Duan","year":"2013","journal-title":"Clin Dev Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"946.e9","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13075-018-1521-3","article-title":"Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells","volume":"20","author":"Saigusa","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fimmu.2012.00071","article-title":"Cellular and molecular mechanisms of chronic inflammation-associated organ fibrosis","volume":"3","author":"Ueha","year":"2012","journal-title":"Front Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/exd.12833","article-title":"ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis","volume":"25","author":"Lee","year":"2016","journal-title":"Exp Dermatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.molimm.2013.05.225","article-title":"IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages","volume":"56","author":"Yin","year":"2013","journal-title":"Mol. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4049\/jimmunol.1200259","article-title":"Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion","volume":"189","author":"Luzina","year":"2012","journal-title":"J Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.immuni.2016.10.031.","volume":"45","author":"de Kleer","year":"2016","journal-title":"Immunity"},{"key":"B77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/imm.12537","article-title":"Interferon-\u03b3 constrains cytokine production of group 2 innate lymphoid cells","volume":"147","author":"Kudo","year":"2016","journal-title":"Immunology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.4049\/jimmunol.0901575","article-title":"IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation","volume":"183","author":"Kurowska-Stolarska","year":"2009","journal-title":"J Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"ra104","DOI":"10.1126\/scisignal.aad5568","article-title":"Loss of epithelial Gq and G11 signaling inhibits TGF\u03b2 production but promotes IL-33-mediated macrophage polarization and emphysema","volume":"9","author":"John","year":"2016","journal-title":"Sci Signal."},{"key":"B80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol Rev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"9517","DOI":"10.1073\/pnas.1119038109","article-title":"Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization","volume":"109","author":"Arranz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1378\/chest.124.4.1206","article-title":"The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis","volume":"124","author":"Tajima","year":"2003","journal-title":"Chest"},{"key":"B83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/01902140701198583","article-title":"ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis","volume":"33","author":"Tajima","year":"2007","journal-title":"Exp Lung Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/path.5092","article-title":"An ST2-dependent role of bone marrow derived group 2 innate lymphoid cells in pulmonary fibrosis","volume":"245","author":"Zhao","year":"2018","journal-title":"J. Pathol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"9517","DOI":"10.1111\/imm.12911","article-title":"The effects of interleukin-33 on airways collagen deposition and matrix metalloproteinase expression in a murine surrogate of asthma","volume":"109","author":"An","year":"2018","journal-title":"Proc Natl Acad Sci USA."},{"key":"B86","doi-asserted-by":"publisher","first-page":"L797","DOI":"10.1152\/ajplung.00513.2005","article-title":"Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases","author":"Park","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e86380","DOI":"10.1172\/jci.insight.86380","article-title":"Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases","volume":"1","author":"Liu","year":"2016","journal-title":"JCI Insight"},{"key":"B88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1600-079X.2007.00504.x","article-title":"Cytoprotective effects of melatonin against necrosis and apoptosis induced by ischemia\/reperfusion injury in rat liver","volume":"44","author":"Kim","year":"2008","journal-title":"J Pineal Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e1889","DOI":"10.1097\/MD.0000000000001889","article-title":"Can serum ST2 levels be used as a marker of fibrosis in chronic hepatitis B infection?","volume":"94","author":"Oztas","year":"2015","journal-title":"Medicine"},{"key":"B90","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3109\/14653249.2011.637668","article-title":"Reduction of galectin-3 expression and liver fibrosis after cell therapy in a mouse model of cirrhosis","volume":"14","author":"de Oliveira","year":"2012","journal-title":"Cytotherapy"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e75361","DOI":"10.1371\/journal.pone.0075361","article-title":"Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease","volume":"8","author":"Traber","year":"2013","journal-title":"PLoS ONE"},{"key":"B93","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2119\/molmed.2014.00178","article-title":"Galectin-3 ablation enhances liver steatosis, but attenuates inflammation and IL-33-dependent fibrosis in obesogenic mouse model of nonalcoholic steatohepatitis","volume":"21","author":"Jeftic","year":"2015","journal-title":"Mol Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/eji.201646890","article-title":"Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers","volume":"47","author":"Forkel","year":"2017","journal-title":"Eur J Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20121964","article-title":"Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages","volume":"210","author":"Molofsky","year":"2013","journal-title":"J Exp Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.4049\/jimmunol.1500020","article-title":"IL-33 reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance","volume":"194","author":"Han","year":"2015","journal-title":"J Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/ni.3085","article-title":"The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells","volume":"16","author":"Vasanthakumar","year":"2015","journal-title":"Nat Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e0188649","DOI":"10.1371\/journal.pone.0188649","article-title":"Human intrahepatic ILC2 are IL-13 positive amphiregulin positive and their frequency correlates with model of end stage liver disease score","volume":"12","author":"Jeffery","year":"2017","journal-title":"PLoS ONE"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J Clin Invest."},{"key":"B100","doi-asserted-by":"publisher","first-page":"848563","DOI":"10.18632\/oncotarget.18335","article-title":"Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis","volume":"25","author":"Vasseur","year":"2017","journal-title":"Oncotarget"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00424-017-1968-0","article-title":"Biology of pancreatic stellate cells\u2014more than just pancreatic cancer","volume":"469","author":"Ferdek","year":"2017","journal-title":"Pflugers Arch."},{"key":"B102","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.cyto.2012.06.286","article-title":"Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells","volume":"60","author":"Schmieder","year":"2012","journal-title":"Cytokine"},{"key":"B103","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gut.2009.193599","article-title":"Expression of interleukin 1-like cytokine interleukin 33 and its receptor complex (ST2L and IL1RAcP) in human pancreatic myofibroblasts","volume":"59","author":"Nishida","year":"2010","journal-title":"Gut"},{"key":"B104","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/MPA.0000000000001034","article-title":"Protective effect of scopoletin against cerulein-induced acute pancreatitis and associated lung injury in mice","volume":"47","author":"Leema","year":"2018","journal-title":"Pancreas"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.celrep.2016.04.049","article-title":"Programming of intestinal epithelial differentiation by IL-33 derived from pericryptal fibroblasts in response to systemic infection","volume":"15","author":"Mahapatro","year":"2016","journal-title":"Cell Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/path.2749","article-title":"Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis","volume":"222","author":"Zhang","year":"2010","journal-title":"J Pathol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrgastro.2016.191","article-title":"The mucosal immune system: master regulator of bidirectional gut-brain communications","volume":"14","author":"Powell","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1172\/JCI88625","article-title":"IL-33 regulates the IgA-microbiota axis to restrain IL-1\u03b1-dependent colitis and tumorigenesis","volume":"126","author":"Malik","year":"2016","journal-title":"J Clin Invest."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/bph.13535","article-title":"Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells","volume":"173","author":"Islam","year":"2016","journal-title":"Br J Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ajpath.2015.11.028","article-title":"IL-33 drives eosinophil infiltration and pathogenic type 2 helper T-cell immune responses leading to chronic experimental ileitis","volume":"186","author":"De Salvo","year":"2016","journal-title":"Am J Pathol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2017.06.017","article-title":"IL-33 and the intestine: the good, the bad, and the inflammatory","volume":"100","author":"Hodzic","year":"2017","journal-title":"Cytokine"},{"key":"B113","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/00365521003624144","article-title":"Regeneration associated growth factor receptor and epithelial marker expression in lymphoid aggregates of ulcerative colitis","volume":"45","author":"Sipos","year":"2010","journal-title":"Scand J Gastroenterol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1172\/JCI44031","article-title":"Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism","volume":"121","author":"Yan","year":"2011","journal-title":"J Clin Invest."},{"key":"B115","doi-asserted-by":"publisher","first-page":"863.e4","DOI":"10.1016\/j.immuni.2017.04.017","article-title":"Mast cells are crucial for induction of Group 2 innate lymphoid cells and clearance of helminth infections","volume":"46","author":"Shimokawa","year":"2017","journal-title":"Immunity"},{"key":"B116","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejps.2018.01.006","article-title":"Role of regulatory T cells in irinotecan-induced intestinal mucositis","volume":"115","author":"Fernandes","year":"2018","journal-title":"Eur J Pharm Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"G12","DOI":"10.1152\/ajpgi.00172.2014","article-title":"TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be rescued by wild-type bone marrow","volume":"308","author":"Judd","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3892\/ol.2018.8728","article-title":"IL-33 notably inhibits the growth of colon cancer cells","volume":"16","author":"Chen","year":"2018","journal-title":"Oncol Lett."},{"key":"B120","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"key":"B121","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.gastro.2006.04.022","article-title":"IL-13 receptor alpha2 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice","volume":"131","author":"Kawashima","year":"2006","journal-title":"Gastroenterology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3748\/wjg.v23.i13.2294","article-title":"Disruption of the TWEAK\/Fn14 pathway prevents 5-fluorouracil-induced diarrhea in mice","volume":"23","author":"Sezaki","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/mc.22491","article-title":"L-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis","volume":"56","author":"Zhang","year":"2017","journal-title":"Mol Carcinog"},{"key":"B124","doi-asserted-by":"publisher","first-page":"E2487","DOI":"10.1073\/pnas.1422445112","article-title":"IL-33 activates tumor stroma to promote intestinal polyposis","volume":"112","author":"Maywald","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B125","doi-asserted-by":"publisher","first-page":"5520","DOI":"10.1038\/s41598-017-05716-z","article-title":"Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min\/+ mice","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/bjc.2015.433","article-title":"An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer","volume":"16","author":"O'Donnell","year":"2018","journal-title":"Oncol Lett."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/mi.2013.124","article-title":"IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice","volume":"7","author":"Guabiraba","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1681\/ASN.2015030261","article-title":"Inflammation in AKI: current understanding, key questions, and knowledge gaps","volume":"27","author":"Rabb","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.gene.2017.11.010","article-title":"Interleukin-33 levels are elevated in chronic allograft dysfunction of kidney transplant recipients and promotes epithelial to mesenchymal transition of human kidney (HK-2) cells","volume":"644","author":"Xu","year":"2017","journal-title":"Gene"},{"key":"B130","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00441-016-2464-0.","article-title":"Epithelial-mesenchymal transition in tissue repair and fibrosis","volume":"365","author":"Stone","year":"2016","journal-title":"Cell Tissue Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2353\/ajpath.2008.070057","article-title":"Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria","volume":"172","author":"Li","year":"2008","journal-title":"Am J Pathol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2009.05.009","article-title":"Epithelial-mesenchymal transition as an explanation for podocyte depletion in diabetic nephropathy","volume":"54","author":"Yamaguchi","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ki.2010.137","article-title":"Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria","volume":"78","author":"Kang","year":"2010","journal-title":"Kidney Int."},{"key":"B134","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fmed.2015.00060","article-title":"Chronic kidney disease and fibrosis: the role of uremic retention solutes","volume":"2","author":"Mutsaers","year":"2015","journal-title":"Front Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000474960","article-title":"Fibrotic changes mediating acute kidney injury to chronic kidney disease transition","volume":"137","author":"\u00d3","year":"2018","journal-title":"Nephron"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1159\/000345151","article-title":"Podocytes express IL-6 and lipocalin 2\/neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury","volume":"121","author":"Lee","year":"2012","journal-title":"Nephron Exp Nephrol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcdb.2016.08.007","article-title":"Wounds that heal and wounds that don't - The role of the IL-33\/ST2 pathway in tissue repair and tumorigenesis","volume":"61","author":"Millar","year":"2017","journal-title":"Semin Cell Dev Biol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cyto.2012.02.008","article-title":"Effects of interleukin-33 on cardiac fibroblast gene expression and activity","volume":"58","author":"Zhu","year":"2012","journal-title":"Cytokine"},{"key":"B139","doi-asserted-by":"publisher","first-page":"51688","DOI":"10.18632\/oncotarget.18393","article-title":"miR-487b mitigates chronic heart failure through inhibition of the IL-33\/ST2 signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.0000047274.66749.FE","article-title":"Identification of serum soluble ST2 receptor as a novel heart failure biomarker","volume":"107","author":"Weinberg","year":"2003","journal-title":"Circulation"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1161\/CIRCULATIONAHA.107.728022","article-title":"Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction","volume":"117","author":"Sabatine","year":"2008","journal-title":"Circulation"},{"key":"B142","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.hfc.2017.08.005","article-title":"Soluble ST2 in heart failure","volume":"14","author":"McCarthy","year":"2018","journal-title":"Heart Fail Clin"},{"key":"B143","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jacc.2007.05.014","article-title":"Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study","volume":"50","author":"Januzzi","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/CIRCHEARTFAILURE.110.958223","article-title":"High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure","volume":"4","author":"Ky","year":"2011","journal-title":"Circ Heart Fail."},{"key":"B145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cca.2014.09.021","article-title":"Soluble ST2 in heart failure","volume":"443","author":"Dieplinger","year":"2015","journal-title":"Clin Chim Acta."},{"key":"B146","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jchf.2016.12.016","article-title":"Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure","volume":"5","author":"Aimo","year":"2017","journal-title":"JACC Heart Fail."},{"key":"B147","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12265-016-9713-1","article-title":"Soluble ST2 and risk of arrhythmias, heart failure, or death in patients with mildly symptomatic heart failure: results from MADIT-CRT","volume":"9","author":"Skali","year":"2016","journal-title":"J Cardiovasc Transl Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCHEARTFAILURE.113.001036","article-title":"Prognostic value of soluble ST2 in the valsartan heart failure trial","volume":"7","author":"Anand","year":"2014","journal-title":"Circ Heart Fail."},{"key":"B149","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jacc.2009.08.047","article-title":"Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction","volume":"55","author":"Weir","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-018-0679-y","article-title":"Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction","volume":"17","author":"Gruzdeva","year":"2018","journal-title":"Cardiovasc Diabetol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e12886","DOI":"10.1111\/eci.12886","article-title":"Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device","volume":"48","author":"Tseng","year":"2018","journal-title":"Eur J Clin Invest."},{"key":"B152","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cll.2013.11.009","article-title":"Soluble ST2 and galectin-3 in heart failure","volume":"34","author":"Shah","year":"2014","journal-title":"Clin Lab Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1002\/eji.200737547","article-title":"IL-33 is a chemoattractant for human Th2 cells","volume":"37","author":"Komai-Koma","year":"2007","journal-title":"Eur J Immunol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/labinvest.2008.61","article-title":"Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway","volume":"88","author":"Aoudjehane","year":"2008","journal-title":"Lab Invest."},{"key":"B155","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/art.37706","article-title":"Interleukin-13-producing CD81 T cells mediate dermal fibrosis in patients with systemic sclerosis","volume":"65","author":"Fuschiotti","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B156","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00296-015-3417-8","article-title":"The IL-33 gene is related to increased susceptibility to systemic sclerosis","volume":"36","author":"Koca","year":"2016","journal-title":"Rheumatol Int."},{"key":"B157","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/sji.12317","article-title":"Increased serum levels of the IL-33 neutralizing sST2 in limited cutaneous systemic sclerosis","volume":"82","author":"Wagner","year":"2015","journal-title":"Scand J Immunol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12016-010-8198-y","article-title":"Diagnosis and classification of systemic sclerosis","volume":"40","author":"Hachulla","year":"2011","journal-title":"Clinic Rev Allerg Immunol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1136\/annrheumdis-2012-202814","article-title":"Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin","volume":"73","author":"Mathes","year":"2014","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02432\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:25:25Z","timestamp":1540340725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02432\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,24]]},"references-count":159,"alternative-id":["10.3389\/fimmu.2018.02432"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02432","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,24]]},"article-number":"2432"}}